Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on
top health stories.
Salmonella decline seen in food poisoning report
17 Apr 2014 at 1:26pm
NEW YORK (AP) ? The government's latest report card on food poisoning shows a dip in salmonella cases but an increase in illnesses from bacteria in raw shellfish. The report counts cases in only 10 states for some of the most common causes of foodborne illness, but is believed to be a good indicator of national food poisoning trends. Highlights from Thursday's report from the Centers for Disease Control and Prevention:
Study: Diabetic heart attacks and strokes falling
16 Apr 2014 at 5:56pm
NEW YORK (AP) ? In the midst of the diabetes epidemic, a glimmer of good news: Heart attacks, strokes and other complications from the disease are plummeting.
Obama: 8 million signed up for health care
17 Apr 2014 at 2:45pm
WASHINGTON (AP) ? Eight million people have signed up for health care through new insurance exchanges and the proportion of younger applicants has increased, President Barack Obama said Thursday. The enrollments exceeded expectations and offered new hope to Democrats who are defending the law ahead of the midterm elections.
Obama argues healthcare law is working, rejects Republican criticism
17 Apr 2014 at 4:56pm
By Steve Holland WASHINGTON (Reuters) - President Barack Obama mounted a vigorous effort on Thursday to show his signature healthcare law is working and dismissed Republican critics who are using flaws in Obamacare to campaign for ousting Democrats from the U.S. Congress in November. Appearing in the White House briefing room days before leaving the national stage for a week-long trip to Asia, Obama used a news conference to make the case that the Affordable Care Act had mended nicely from its disastrous October rollout. For the healthcare law to succeed, young, healthy people must sign up and pay premiums to offset the healthcare costs for older Americans. Obama's remarks reflected deep concerns at the White House that Republicans may be able to topple Democrats from control of the U.S. Senate in November elections and build on their majority in the House of Representatives.
Wall Street Week Ahead: Spring fever brings hope for U.S. earnings
17 Apr 2014 at 4:20pm
By Chuck Mikolajczak NEW YORK (Reuters) - Earnings season shifts into high gear next week, and with nearly one-third of S&P 500 names set to post results, investors hope the news provides a catalyst to buy stocks and leave the market's recent weakness in the dust. Several behemoths, including Apple, the largest U.S. company by market value, as well as Microsoft, McDonald's and AT&T , are due to report earnings. They'll be accompanied by highfliers like Netflix and Facebook, giving the first real cross-section of the state of corporate America as temperatures rise across the country and investors hope to put the cold weather behind them. Strategists will also be looking for clues on how badly China's slowdown hits U.S. corporate results.
Obama budget would boost U.S. tax revenue, cut deficits: CBO
17 Apr 2014 at 4:08pm
By David Lawder WASHINGTON (Reuters) - President Barack Obama's fiscal 2015 budget request would boost U.S. tax revenue by nearly $1.4 trillion over 10 years if fully enacted, cutting deficits by $1.05 trillion while funding new spending, the Congressional Budget Office said on Thursday. But the non-partisan agency's analysis was less optimistic than the White House's own projections - showing that cumulative deficits would total $6.6 trillion over 10 years, compared to $4.9 trillion under the Obama plan when it was released in March. A key difference between the two deficit pictures is CBO's projection of slower economic growth, partly resulting in lower revenue collections. The likelihood that Congress will advance Obama's plan in its entirety is virtually nil, but the CBO's latest analysis will feed campaign messaging by Democrats and Republicans ahead of congressional elections in November.
Forty years on, bullying takes its toll on health and wealth
17 Apr 2014 at 4:05pm
The negative social, physical and mental health effects of childhood bullying are still evident nearly 40 years later, according to research by British psychiatrists. In the first study of its kind to look at the effects of childhood bullying beyond early adulthood, the researchers said its impact is "persistent and pervasive", with people who were bullied when young more likely to have poorer physical and psychological health and poorer cognitive functioning at age 50. "The effects of bullying are still visible nearly four decades later ... with health, social and economic consequences lasting well into adulthood," said Ryu Takizawa, who led the study at the Institute of Psychiatry at King's College London. The findings, published in the American Journal of Psychiatry on Friday, come from the British National Child Development Study which includes data on all children born in England, Scotland and Wales during one week in 1958.
In a cloning first, scientists create stem cells from adults
17 Apr 2014 at 3:36pm
By Sharon Begley NEW YORK (Reuters) - Scientists have moved a step closer to the goal of creating stem cells perfectly matched to a patient's DNA in order to treat diseases, they announced on Thursday, creating patient-specific cell lines out of the skin cells of two adult men. The advance, described online in the journal Cell Stem Cell, is the first time researchers have achieved "therapeutic cloning" of adults. Technically called somatic-cell nuclear transfer, therapeutic cloning means producing embryonic cells genetically identical to a donor, usually for the purpose of using those cells to treat disease. But nuclear transfer is also the first step in reproductive cloning, or producing a genetic duplicate of someone - a technique that has sparked controversy since the 1997 announcement that it was used to create Dolly, the clone of a ewe.
Mediterranean diet may slow diabetes progression
17 Apr 2014 at 2:39pm
By Kathryn Doyle NEW YORK (Reuters Health) - For people recently diagnosed with type 2 diabetes, eating lots of olive oil, fish and whole grains slows progression of the disease more than restricting fat, according to a new analysis. In a trial that followed participants for more than eight years, those following a so-called Mediterranean diet went significantly longer before needing diabetes medication and more of them had their diabetes go into remission, compared to those on a low-fat diet. "There's been lots of epidemiology suggesting that a Mediterranean diet was beneficial with metabolic syndrome and diabetes," Dr. Leanne Olansky told Reuters Health. "But this was a randomized controlled trial, so we know it really was the diet causing the results," she said.
'X-Men' director Bryan Singer accused of drugging, raping teen
17 Apr 2014 at 2:20pm
By Eric Kelsey LOS ANGELES (Reuters) - Director Bryan Singer, weeks before the release of his blockbuster "X-Men" action film, "X-Men: Days of Future Past," has been accused of drugging and raping a teenage boy in California and Hawaii in the late 1990s. The lawsuit filed on Wednesday in U.S. Court in Hawaii alleges that Singer, 48, used his influence as a Hollywood insider as well as a range of drugs and alcohol to force anal and oral sex on the boy while promising him roles in his films. Michael Egan seeks unspecified damages and a jury trial after wide-ranging abuses at California and Hawaii house parties beginning in the late 1990s, according to the civil action.
FDA Warns Against Hysterectomy Procedure Technique
17 Apr 2014 at 2:17pm
The FDA warns common surgical technique could lead to dangerous spread of cancer cells.
More Weak Claims on Cotton?s Insurance Ties
17 Apr 2014 at 2:12pm
Another liberal group is attacking Republican Rep. Tom Cotton in Arkansas by saying Cotton has experience in the insurance industry and is attempting to undermine Medicare. Cotton's insurance experience is limited to consulting work for a federal agency.
Manager at Japan's Fukushima plant admits radioactive water 'embarrassing'
17 Apr 2014 at 2:04pm
By Yuka Obayashi OKUMA, Japan (Reuters) - The manager of the Fukushima nuclear power plant admits to embarrassment that repeated efforts have failed to bring under control the problem of radioactive water, eight months after Japan's prime minister told the world the matter was resolved. Tokyo Electric Power Co, the plant's operator, has been fighting a daily battle against contaminated water since Fukushima was wrecked by a March 2011 earthquake and tsunami. Prime Minister Shinzo Abe's government pledged half a billion dollars last year to tackle the issue, but progress has been limited. "It's embarrassing to admit, but there are certain parts of the site where we don't have full control," Akira Ono told reporters touring the plant this week.
Earnings lift S&P 500, Nasdaq; S&P's best week since July
17 Apr 2014 at 1:59pm
By Ryan Vlastelica NEW YORK (Reuters) - Stocks ended a holiday-shortened week with mostly modest gains on Thursday, though the S&P 500 notched its biggest weekly advance since July as Morgan Stanley and General Electric rallied after strong results. The two were the latest to post earnings that topped expectations, helping to lift the S&P 500 and the Nasdaq to their fourth straight daily advance. Tech bellwethers Google and IBM fell on disappointing figures and limited the broader market's gain. IBM's slide pushed the Dow into slightly negative territory at the close.
Free dermatology drug samples come at a cost
17 Apr 2014 at 1:52pm
By Andrew M. Seaman NEW YORK (Reuters Health) - Dermatologists tend to prescribe more expensive medications when they also give their patients drug samples, according to a new U.S. study. "If you're a patient who receives a sample, you may perceive that doctor is giving you better care because they gave you a gift," Dr. Alfred Lane told Reuters Health. "But that doctor may have increased your medical costs by giving you that sample." Lane is the study's senior author, from the Stanford University School of Medicine in Stanford, California. Addressing fellow dermatologists, he added, "You have to realize that these samples are making you write more expensive prescriptions." In an editorial accompanying the new study in JAMA Dermatology, Dr. Kenneth Katz and colleagues from Kaiser Permanente Northern California note that the drug industry in 2011 distributed $6.3 billion of samples.